MOLECULAR MECHANISMS OF OBSTETRIC APS
Khalmirzaeva M. Kurmanova A. Salimbayeva D. Urazbayeva G. Kurmanova G. Kypshakbayeva Z. Koshkimbayeva G.
2025Georgian Association of Business Press
Georgian Medical News
2025#363Issue 6131 - 144 pp.
Introduction: Antiphospholipid syndrome is an autoimmune disease marked by antiphospholipid antibodies, causing thrombosis and obstetric complications. Objectives: This study explores molecular mechanisms, endometrial receptivity, and clinical parameters linked to APS, focusing on pregnancy complications such as miscarriage, preterm delivery, recurrent implantation failure (RIF), and thrombosis. Patients and Methods: A systematic review was conducted through Scopus, WoS, PubMed, Cochrane, and Google Scholar, including studies published between 2019 and 2024. 17 relevant original research studies were selected, focusing on clinical trials and observational studies. Narrative reviews and meta-analyses were excluded, with priority given to preeclampsia-specific studies to explore the immune and vascular dysfunction link in APS patients. Results: Key findings include the correlations between elevated antiphospholipid antibodies (aPLs), including aCL and aβ2GPI, poor vascularization of the uterus, and recurrent pregnancy loss (RPL) reports. Preeclampsia is closely linked to APS, resulting in immune and vascular dysfunctions that exacerbate complications, including miscarriage, preterm delivery, and fetal death. ELISA, Doppler ultrasound, and genetic testing are some of the diagnostic methods applied. The aPL autoantibodies along with inflammatory markers like CRP and TNFSF13B, an increase in cytokine imbalance, are associated with many pregnancy complications such as early-stage miscarriage and preterm delivery. Deficient inflammation resolution and adequate uterine perfusion, abnormal uterine blood perfusion, and chronic infection significantly impact rates of perinatal illness and death which emphasizes the problem in identifying and managing APS. Conclusion: This review focuses on the effects of the antiphospholipid syndrome on the endometrial receptivity and pregnancy outcomes, paying special attention to how early diagnosis and treatment can enhance the chances of a successful pregnancy and reduce complications.
Antiphospholipid syndrome , autoantibodies , endometrial receptivity , pregnancy complications
Text of the article Перейти на текст статьи
Department of Obstetrics and Gynecology, Al-Farabi Kazakh National University, Almaty, Kazakhstan
Head of Obstetrics and Gynecology Department of NJSC “Al-Farabi Kazakh National University”, Almaty, Kazakhstan
Head of Strategic Development and Science Department, Scientific Center of Obstetrics, Gynecology and Perinatology, Almaty, Kazakhstan
Head of Scientific Center of Obstetrics, Gynecology and Perinatology JSC, Almaty, Kazakhstan
Department of General medical practice, Al-Farabi Kazakh National University, Almaty, Kazakhstan
Obstetrician-gynecologist, Al-Farabi Kazakh National University, Almaty, Kazakhstan
The Municipal State Enterprise “City Center for Human Reproduction” under the Public Health Department, Almaty, Kazakhstan
Department of Obstetrics and Gynecology
Head of Obstetrics and Gynecology Department of NJSC “Al-Farabi Kazakh National University”
Head of Strategic Development and Science Department
Head of Scientific Center of Obstetrics
Department of General medical practice
Obstetrician-gynecologist
The Municipal State Enterprise “City Center for Human Reproduction” under the Public Health Department
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026